Canada markets closed

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDY.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.24600.0000 (0.00%)
At close: 09:06AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
809,233
850,733
1,031,160
1,140,313
833,803
Cost of Revenue
64,158
70,628
84,062
80,955
64,812
Gross Profit
745,075
780,105
947,098
1,059,358
768,991
Operating Expenses
Research Development
253,257
243,763
226,851
224,387
139,268
Selling General and Administrative
249,123
272,859
442,589
482,140
443,575
Total Operating Expenses
636,844
650,141
822,727
869,106
600,639
Operating Income or Loss
108,231
129,964
124,371
190,252
168,352
Interest Expense
2,304
3,066
1,538
1,055
5,601
Income Before Tax
96,684
97,528
132,294
215,921
176,701
Income Tax Expense
-5,231
-10,922
-4,979
3,540
12,442
Income from Continuing Operations
101,916
108,450
137,272
212,381
164,259
Net Income
102,188
108,627
137,997
213,296
164,663
Net Income available to common shareholders
102,188
108,627
137,997
213,296
164,663
Basic EPS
0.21
0.11
0.13
0.21
0.17
Diluted EPS
0.21
0.11
0.13
0.20
0.17
Basic Average Shares
915,702
1,034,048
1,030,195
1,040,750
989,411
Diluted Average Shares
915,702
1,034,170
1,031,233
1,044,766
989,411